Alto Neuroscience, Inc. SEC filings ANRO
Alto Neuroscience, Inc. has 196 filings in SEC EDGAR's recent list, going back to Nov 22, 2023. Its latest annual report, Form ARS, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 27, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 20, 2026 | — |
| CORRESP | Letter to the SEC | Apr 17, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2026 | — |
| EFFECT | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| D | Filing | Oct 27, 2025 | — |
| DEFR14A | Filing | May 9, 2025 | — |
| EFFECT | Filing | Feb 11, 2025 | — |
| CORRESP | Letter to the SEC | Feb 7, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2025 | — |
| SEC STAFF LETTER | Filing | Feb 2, 2024 | — |
| EFFECT | Filing | Feb 1, 2024 | — |
| CERT | Nyse certification | Jan 30, 2024 | — |
| 8-A12B | Filing | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 25, 2024 | — |
| CORRESP | Letter to the SEC | Jan 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 19, 2024 | — |
| CORRESP | Letter to the SEC | Jan 12, 2024 | — |
| SEC STAFF LETTER | Filing | Jan 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2024 | — |
| DRSLTR | Filing | Dec 28, 2023 | — |
| DRS/A | Filing | Dec 28, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2023 | — |
| D | Filing | Nov 27, 2023 | — |
| D | Filing | Nov 27, 2023 | — |
| D | Filing | Nov 27, 2023 | — |
| D | Filing | Nov 27, 2023 | — |
| DRS | Filing | Nov 22, 2023 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANRO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1999480
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.